Miravant’s PhotoPoint PDT May Inhibit Failure of Vascular Access Grafts in Hemodialysis Patients
Miravant Medical Technologies (OTCBB:MRVT), a pharmaceutical company specializing in PhotoPoint(TM) photodynamic therapy (PDT), today announced novel results for the prevention of vascular access graft failure,
